San Diego-based Gen-Probe has acquired GTI Diagnostics, a specialty diagnostics firm focused on the transplantation, blood bank and specialty coagulation markets, the firm said Wednesday. The deal was worth $53M in cash. GTI was owned by private equity firm Riverside Company and other investors.